• Explore /
  • Poster
  • / A phase I study of a mutant KRAS-targeted long peptide vaccine in patients at high risk of developing pancreatic cancer.

A phase I study of a mutant KRAS-targeted long peptide vaccine in patients at high risk of developing pancreatic cancer.

Abstract Poster

Authors

Saurav Haldar

Saurav Daniel Haldar

Department of Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD;

Saurav Daniel Haldar , Carol Judkins , Anna Ferguson , Elizabeth Abou Diwan , Su Jin Lim , Hao Wang , Julie Nauroth , Michael Goggins , Dan Laheru , Elizabeth M. Jaffee , Nilofer Saba Azad , Neeha Zaidi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Prevention, Screening, and Hereditary Cancers

Clinical Trial Registration Number

NCT05013216

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr TPS758)

DOI

10.1200/JCO.2023.41.4_suppl.TPS758

Abstract #

TPS758

Poster Bd #

P14

Abstract Disclosures

Similar Posters

First Author: Saurav Daniel Haldar

First Author: Zev A. Wainberg

First Author: Tariq Arshad

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Prognostic indicators of KRAS G12X mutations in pancreatic cancer.

Prognostic indicators of KRAS G12X mutations in pancreatic cancer.

First Author: Bach Ardalan